Methylene Blue-Enhanced Ultrafiltration Improves Outcomes After Cardiopulmonary Bypass

NCT07212842 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Cardiopulmonary Bypass Surgery
Aortic Valve Surgery
Mitral Valve Surgery
Myocardial Revascularization Surgery With Extracorporeal Circulation

Interventions

DRUG: Methylene Blue
PROCEDURE: Conventional ultrafiltration
PROCEDURE: Zero-balance ultrafiltration

Sponsor

University of Sao Paulo